Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 hasil
Monoclonal antibodies that neutralize anthrax toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of immunology and specifically to monoclonal antibodies that bind and/or neutralize anthrax lethal factor (LF) or edema factor (EF).
REFERENCE TO SEQUENCE LISTING, TABLE, OR COMPUTER PROGRAM LISTING
The present application is being
Monoclonal antibodies that neutralize anthrax toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of immunology and specifically to monoclonal antibodies that bind and/or neutralize anthrax lethal factor (LF) or edema factor (EF).
REFERENCE TO SEQUENCE LISTING, TABLE, OR COMPUTER PROGRAM LISTING
The present application is being
Monoclonal antibodies that neutralize anthrax toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of immunology and specifically to monoclonal antibodies that bind and/or neutralize anthrax lethal factor (LF) or edema factor (EF).
REFERENCE TO SEQUENCE LISTING, TABLE, OR COMPUTER PROGRAM LISTING
The present application is being
Monoclonal antibodies that neutralize anthrax toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
REFERENCE TO SEQUENCE LISTING
This application contains a Sequence Listing submitted as an electronic text file named "NIH352.sub.--001VPC_SEQ_LISTING.TXT", having a size in bytes of 98 KB, and created on Aug. 24, 2009. The information contained in this electronic file is hereby incorporated by
Monoclonal antibodies that neutralize anthrax toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates generally to the field of immunology and specifically to monoclonal antibodies that bind and/or neutralize anthrax lethal factor (LF) or edema factor (EF).
REFERENCE TO SEQUENCE LISTING
This application contains a Sequence Listing submitted as an
Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates generally to the fields of bacteriology, immunology, and vaccine technology.
The present invention also relates to Bacillus anthracis proteins as novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure
Anthrax compositions and methods of use and production
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to the field of immunology and more particularly relates to methods and compositions for treating, preventing or reducing anthrax infection in humans or animals.
BACKGROUND OF THE INVENTION
Anthrax is a disease caused by the sporulating bacteria Bacillus
Process for the preparation of non-toxic anthrax vaccine
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates to a Recombinant DNA construct and a process for the preparation of a nontoxic anthrax vaccine.
BACKGROUND OF THE INVENTION
Anthrax, a zoonotic disease is caused by gram-positive, sporulating bacteria, Bacillus anthracis. Humans are accidental hosts
Methods and compositions relating to anthrax pathogenesis
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention generally relates to crystalline Edema Factor (EF) without substrate, crystalline Edema Factor-calmodulin complex without substrate and the structures of Edema Factor without substrate and Edema Factor-calmodulin complex as determined by x-ray
Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The inventive subject matter relates to a competitive fluorescence method for estimating the concentration in a sample of Bacillus anthracis protein or specific antibody. The method contemplates the use of FLT, FRET or FP.
BACKGROUND OF INVENTION
Oral fluids have been
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
